Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Yellow Fever ACIP Vaccine Recommendations

Advisory Committee for Immunization Practices (ACIP)

MMWR image

as Published in Morbidity and Mortality Weekly Report (MMWR)

The Advisory Committee on Immunization Practices (ACIP) provides advice and guidance to the Director of the CDC regarding use of vaccines and related agents for control of vaccine-preventable diseases in the civilian population of the United States. Recommendations made by the ACIP are reviewed by the CDC Director and, if adopted, are published as official CDC/HHS recommendations in the Morbidity and Mortality Weekly Report (MMWR).

Updated Guidance for Yellow Fever Vaccine

To avoid a lapse in yellow fever vaccine availability in the United States, the manufacturer, Sanofi Pasteur, has received approval from FDA to import Stamaril yellow fever vaccine. Stamaril is produced by Sanofi Pasteur in France and has comparable safety and efficacy to YF-Vax.  See the MMWR Addressing a Yellow Fever Vaccine Shortage — United States, 2016–2017 for further information for providers regarding yellow fever vaccine.

CURRENT Yellow Fever Vaccine Recommendations


ARCHIVED Historical Yellow Fever Immunization Publications

For your convenience, these archived publications can be used for historical and research purposes.

Top of Page